© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Rifamycin S Sodium belongs to a group of antibiotics known for their capability to tackle bacterial infections that often resist other treatments. Formed as a sodium salt of Rifamycin S, this substance stands out because it combines distinct antibacterial potency with a solid foundation in organic chemistry. Grown out of decades of research on actinomycete-derived antibiotics, this compound found its foothold in the world of medicine and raw materials directly from the fermentation broth of Streptomyces mediterranei. Over the years, experts recognized it for features that stretch beyond the plain medical use cases. Its manipulation relies on understanding the specifics of its molecules and the risks tied to handling chemical raw materials of this grade.
Rifamycin S Sodium appears mostly as a light yellow to brownish powder, loose flakes, or crystalline solid, depending on production and storage conditions. Its crystalline form offers a diagnostic look under polarized light, with pearl-like facets reflecting its purity and composition. The compound shows moderate solubility in water, forming clear, deep yellow-orange solutions that clue trained operators into its chemical state. That solubility links to its molecular structure: C37H46NNaO12, a formula that balances 37 carbon atoms, 46 hydrogens, 1 nitrogen, 1 sodium, and 12 oxygens. The molar mass lands near 741.74 g/mol, a hefty number in the world of antibiotics. Density holds close to 1.5 g/cm³ when compressed or analyzed as a fine solid—details that shape its use in both lab-scale and industrial settings.
Chemically, Rifamycin S Sodium pulls together a complex macrocyclic structure, built on an ansa chain bridging aromatic rings and functional groups that carry the key antibacterial action. The sodium salt formation boosts its stability and shelf-life, shifting its behavior in solutions compared to neutral rifamycins. Detailed specifications highlight criteria such as water content, assay percent (often above 95% for premium grades), and allowed traces of related compounds. For international transport and trade, the Harmonized System (HS) Code for Rifamycin S Sodium generally falls under 29419090, which covers other antibiotics not named elsewhere. This classification ensures that shippers, importers, and regulatory bodies speak the same language on paperwork, customs duties, and hazard labeling — not a small thing in global supply chains glued together by raw material flows.
Markets see this antibiotic sold as solid powder, coarse flakes, or even granules that steady the hand during weighing and mixing. Some formulation labs opt for ready-made solutions, carefully buffered and stabilized, to simplify downstream processing. No matter the form, this compound requires airtight containers and protection from light: even a little exposure can prompt degradation, lowering potency and safety. Density data swings with the physical type, but bulk powders usually measure close to 0.4 to 0.7 g/cm³ loose, yet increase when tapped or settled. Storage areas demand low humidity, temperatures below 25°C, and chemical hazard isolation. Laboratories and manufacturing plants enforce these rules based on real stories of loss and contamination when corners get cut.
Handling Rifamycin S Sodium carries real-world safety risks, not just on paper but in daily routines. Airborne dust irritates eyes, skin, and respiratory systems, calling for gloves, goggles, and dust masks. Direct contact can trigger allergic or sensitizing reactions in a portion of handlers. Material Safety Data Sheets (MSDS) outline its profile: not flammable, though severe thermal decomposition releases harmful gases. Accidental spillage poses both worker and environmental hazards, as this substance affects aquatic life at very low concentrations. Waste must travel under controlled disposal—not washed down sinks or tossed with regular lab debris. Pharmacies, chemical companies, and producers abide by local and global hazardous material protocols, and every year, enforcement agencies catch someone who ignored the fine print.
Few antibiotics deliver the spectrum and robust performance that Rifamycin S Sodium brings, especially for resistant strains plaguing hospitals or animal health sectors. While its medical use gets all the headlines, downstream industries draw on it as an intermediate to synthesize derivatives, create diagnostic tools, and run research into next-generation drugs. The supply chain stretches from fermentation vats in specialist plants to purification, drying, and a global network of trade hubs. Each bag, drum, or bottle reflects a careful calibration of purity, stability, and traceability—cornerstones that build trust between producers and buyers. Decision-makers regularly face shortages, price swings, or regulatory updates, which reminds everyone that understanding both physical and molecular properties matters beyond any single batch.
Quality control often tests patience in this field: stray humidity, improper storage, or cross-contamination can toss entire batches. Real protection comes from routine independent testing—sample assays, impurity fingerprints, infrared spectra, sometimes even X-ray crystallography for assurance. For smaller labs and new manufacturers, cost and scalability create a squeeze: affordable, reliable sourcing gets harder without robust networks. Solutions include shared procurement, co-investment in analytical tools, and robust digital tracking using lot numbers tied to molecular assessments. Regulatory awareness needs constant updating, with international frameworks evolving on topics from antimicrobial stewardship to hazardous goods shipping. Environmental concerns lead leaders to invest in greener production and closed-loop waste controls, not out of marketing, but as insurance against rising ecological and legal risks. Staying ahead demands more than memorizing data sheets—it takes field experience, peer partnerships, and a willingness to learn from fumbles.
